Dataset Information

Diffuse cavernous hemangiolymphangioma of the rectosigmoid, diagnosed by contrast-enhanced EUS.

ABSTRACT:

SUBMITTER: Kusunoki R

PROVIDER: S-EPMC7426648 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Diffuse cavernous hemangiolymphangioma of the rectosigmoid, diagnosed by contrast-enhanced EUS.

Kusunoki Ryusaku R Fujishiro Hirofumi H Kitagawa Koki K Kinoshita Yoshikazu Y Ishihara Shunji S

VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy 20200529 8

PMID: 32821870

Similar Datasets

Project description:BackgroundRecent advances in EUS techniques (real-time EUS elastography and contrast-enhanced EUS) have allowed a better characterization of focal pancreatic masses. Mean strain histograms (SHs) are considered a good parameter for the semi-quantitative evaluation of focal pancreatic masses, alongside complementary contrast-enhanced EUS parameters which can be quantified during both the early arterial and late venous phase.Materials and methodsThe study design was prospective, blinded, and multicentric, assessing real-time EUS elastography and contrast-enhanced EUS results for the characterization of focal pancreatic masses using parametric measurements, in comparison with pathology which is the gold standard. SHs were performed based on the embedded software of the ultrasound system, with the values being reversed as opposed to our initially published data on hue histograms. Consequently, a cutoff of 80 was derived from previous multicentric trials. Contrast-enhanced EUS also allowed the focal masses to be classified as hyper-, iso-, or hypoenhanced in comparison with the normal pancreatic parenchyma. EUS-FNA was then performed for all patients, with a positive cytological diagnosis taken as a final proof of malignancy for the pancreatic masses. The diagnoses obtained by EUS-FNA were verified further either by surgery or during a clinical follow-up of at least 6 months.ResultsA total number of 97 consecutive patients with focal pancreatic masses were included in the study. Based on previously defined cutoffs of 80, the values of sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the mean SHs for the diagnosis of pancreatic cancer were 100%, 29.63%, 78.65%, 100%, and 80.41%, respectively. Corresponding values for contrast-enhanced EUS (taking into consideration hypoenhencement as a predictive factor of malignancy) were 98.57%, 77.78%, 92%, 95.45%, and 92.78%, respectively. Combining contrast enhancement-EUS (hypoenhencement) and semi-quantitative EUS elastography (SH cutoffs <80), the resulting values corresponding for sensitivity, specificity, and accuracy were 98.57%, 81.48%, and 93.81%, respectively.ConclusionThe current study using objective parametric tools for both EUS elastography and contrast-enhanced EUS confirmed the results of previous studies and meta-analyses that indicated a complementary role for the differential diagnosis of focal pancreatic masses. Moreover, the best values for the receiver operating curves were obtained using a sequential clinical algorithm based on the initial use of elastography, followed by contrast enhancement.

Dataset Information

Diffuse cavernous hemangiolymphangioma of the rectosigmoid, diagnosed by contrast-enhanced EUS.

Publications

Diffuse cavernous hemangiolymphangioma of the rectosigmoid, diagnosed by contrast-enhanced EUS.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets